Outcomes and characteristics of non-melanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib
Rampotas, A Carter-Brzezinski, Luke Somervaille, Tim C Forryan, J Panitsas, FP Harrison, CN Witherall, R Innes, AJ Wallis, L Butt, NM
Rampotas, A
Carter-Brzezinski, Luke
Somervaille, Tim C
Forryan, J
Panitsas, FP
Harrison, CN
Witherall, R
Innes, AJ
Wallis, L
Butt, NM
Citations
Altmetric:
Abstract
Non-melanoma skin cancers in ruxolitinib-treated MPN patients behave aggressively, with adverse features and high recurrence. In our cohort, mortality from metastatic NMSC exceeded that from myelofibrosis . Vigilant skin assessment, counselling on NMSC risks, and prospective ruxolitinib-NMSC studies are crucial.
Authors
Rampotas, A
Carter-Brzezinski, Luke
Somervaille, Tim C
Forryan, J
Panitsas, FP
Harrison, CN
Witherall, R
Innes, AJ
Wallis, L
Butt, NM
Psaila, B
Mead, AJ
Carter, M
Godfrey, AL
Laing, H
Garg, M
Francis, S
Ewing, J
Teh, CH
Cowan, HB
Dyer, P
McConville, C
Wadelin, F
Ali, S
McGregor, AD
Kulakov, E
McLornan, DP
Lambert, J
Carter-Brzezinski, Luke
Somervaille, Tim C
Forryan, J
Panitsas, FP
Harrison, CN
Witherall, R
Innes, AJ
Wallis, L
Butt, NM
Psaila, B
Mead, AJ
Carter, M
Godfrey, AL
Laing, H
Garg, M
Francis, S
Ewing, J
Teh, CH
Cowan, HB
Dyer, P
McConville, C
Wadelin, F
Ali, S
McGregor, AD
Kulakov, E
McLornan, DP
Lambert, J
Description
Date
2023
Publisher
Collections
Keywords
Type
Article
Citation
Rampotas A, Carter-Brzezinski L, Somervaille TC, Forryan J, Panitsas FP, Harrison CN, et al. Outcomes and Characteristics of Non-Melanoma Skin Cancers in Patients with Myeloproliferative Neoplasms on Ruxolitinib. Blood. 2023 Nov 14. PubMed PMID: 37963262. Epub 2023/11/14. eng.